Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder
Journal of Experimental Pharmacology 2021 Giacomo Grassi, Chiara Cecchelli, Luisa Vignozzi et al. 42 citations
Treatment-resistance is a frequent condition for obsessive-compulsive disorder (OCD). Over the past decades, a lot of effort has been made to address this issue, and several augmentation strategies of serotonergic drugs have been investigated. Antidopaminergic drugs are considered the first choice as augmentation strategy for treatment-resistant OCD patients, but they seem to work only for a...